[一季报]老百姓(603883):老百姓2025年一季度报告（英文版）
原标题:老百姓:老百姓2025年一季度报告（英文版） LBXPharmacyChainJointStockCompany 2025FirstQuarterReport TheCompany'sBoardofDirectorsandalldirectorsundertakethatnothinghereofcontainsany falserecords,misleadingrepresentationsormajoromissions,andarelegallyliableforauthenticity, accuracyandintegrityofthecontentshereof.ImportantNotes TheCompany'sBoardofDirectors,BoardofSupervisors,anddirectors,supervisors,andseniorexecutivesguaranteethatthecontentofthequarterlyreportistrue,accurate,andcomplete,containsnofalserecords,misleadingstatements,ormaterialomissions,andbearindividualandjointlegalliabilities.TheCompany'sprincipal,personinchargeofaccountingwork,andpersoninchargeofaccountingdepartment(chiefaccountant)guaranteethatthefinancialinformationinthequarterlyreportistrue,accurate,andcomplete. Whetherthefirstquarterfinancialstatementshavebeenaudited □Yes√No I. MainFinancialData (I) MainAccountingDataandFinancialIndicators Unit:YuanCurrency:RMB
√Applicable□NotApplicable Unit:YuanCurrency:RMB
□Applicable√NotApplicable Changesinmainaccountingdataandfinancialindicators,andreasons√Applicable□NotApplicable
(I) Totalnumberofordinaryshareholdersandpreferredshareholderswithrestoredvotingrights,andshareholdingoftoptenshareholderstable Unit:Share
Changesintop10shareholdersandtop10non-restrictedcirculatingshareholderscomparedtothepreviousperiodduetolending/returnreasonsinsecuritiesrefinance □Applicable√NotApplicable III. OtherReminders Otherimportantinformation concerningtheCompany's operatingsituation duringthereporting periodthatrequiresinvestorattention √Applicable□NotApplicable (I)OperatingSituationandAnalysis 1.Optimizemarketlayout (1)Focusonadvantageousandsmall-townandruralmarkets,expandsteadilyThe Company expands its market through a multi-pronged, in-depth cultivation modelof "four horsecarriages":directoperation,M&A,franchising,andalliance,havingachievedbroadcoverageofthenationalmarket.AsoftheendofQ12025,theCompany'schainnetworkcovered18provincial-levelmarkets,over150prefecture-levelcitiesandabove,with15,252stores,including9,844directly-operatedstoresand5,408franchise stores.InQ12025,211newstoreswereadded,including24directly-operatedstoresand187franchisestores,while236storeswereadjustedandclosed,Optimizingmarketlayout. TheCompanyfocusesonlayoutin11advantageousprovincestoincreasemarketshare.Amongthenewstoresaddedinthefirstquarter,directly-operatedstoresinadvantageousprovincesandkeycitiesaccountedfor92%. Meanwhile, the Company optimizes its layout based on market changes by relocating and closingloss-makingstores,enhancingoverallprofitability. Activelyexpandintosmall-townandruralmarketswithlargepopulationsandlowoperatingcosts.AsofMarch31,2025,theproportionofstoresinprefecture-levelcitiesandbelowwas77%;amongthenewstoresaddedfromJanuarytoMarch2025,theproportionofstoresinprefecture-levelcitiesandbelowwas86%.(2)Franchiselayouttapsintoexistingpharmacies,integratingthemarketFirst,theCompany'sfranchisebusinessaccelerateslayoutintheexistingmarket,focusingonrecruitingaccountedfor62%ofnewfranchises,ayear-on-yearincreaseof34percentagepoints.Second,strengthenthelayeredandgradedmanagementoffranchisestores,optimizingoperationalstrategiesfordifferentstoretypes.Third,resourcesfromtheGroup'ssupplychaincenterfurthersupportfranchisedevelopment.Fourth,theGroup'sinformationcenterempowersfranchisestores,withinformationsystemssupportingcostreductionandefficiencyimprovement.InQ12025,theCompany'sfranchisebusinessachieveddistributionrevenueexceedingRMB580million. (3)Alliancedeeplyempowerspartners,broadlycooperating First,integratesupplychainresourcestoreducecostsandincreaseefficiencyforcooperativeenterprises.Second,provide intelligentanalysis anddecision-makingreports through full-categorydata docking. Third, regularlyorganizeemployeetrainingforcooperativeenterprisestoenhancebusinesscapabilities.InQ12025,the totalannualretailscaleofallianceenterprisesexceededRMB30billion,withthenumberofalliancestoresreaching21,000+,amongwhich127arecooperativeenterpriseswithcompanyshareholding,correspondingtoaretailscaleofRMB8.27billionand7,086stores.Inthefirstquarter,theCompany'salliancebusinessachieveddistributionsalesofRMB126million,ayear-on-yearincreaseof34%.2.Enhanceprofessionalcapabilities (1)Medicalinsurancestoresstrengthencompliancemanagement,reducingrisksIn2025,theCompanycontinuedtostrengthentheoperationalmanagementcapabilitiesofmedicalinsurancestores.First,strengthenthemanagementofmedicalinsurancestores,respondtopolicychanges,andimproveoperationalmanagementbasedonregulatoryrequirements.Second,continuouslypromotelong-termstableandcompliant development, strengthening compliance control through compliance systems, self-inspectionmechanisms, etc., to reduce operating risks. Third, promote the operation of self-built internet hospitals, standardizeprescriptionmanagement,andenhancetheabilitytohandleprescriptionoutflow.Asoftheendofthereportingperiod,theCompanyhadatotalof9,158directly-operatedstoreswithmedicalinsurancequalifications,accountingfor93.03%ofdirectly-operatedstores.Thenumberofstoreswithoutpatient poolingqualificationswas5,452(including4,155directly-operatedand1,297franchisestores),withoutpatient poolingstoresaccountingfor42.21%ofdirectly-operatedstores. (2)Professionalpharmacyattributescontinuouslyconsolidated,attractingcustomerflowBuildprofessionalpharmaciestohighstandards,prioritizingtheacceptanceofoutflowingprescriptions.Attheendofthereportingperiod,theCompanyhad1,728storesdesignatedfor"outpatientchronicandspecialdiseases", accounting for 17.55% of directly-operated stores; the number of stores with dual-channel qualificationsreached331.TheCompanyowns176DTPpharmacies,covering14provincesand55citiesnationwide. Providehigh-qualitypharmaceuticalservices.TheCompanystrengthenstheprofessionalservicecapabilitiesofpharmaciesthroughan"online+offline"trainingsystem,encouragingemployeestoobtainqualificationsaslicensedpharmacistsandpharmacists.Utilizingonlineinstantlearningtoolstosolidifytheoreticalfoundations andenhancingpracticalskillsthroughofflinecountertraining.Additionally,continuouslyempowerstorestaffthroughdigitaltoolstoprovidecustomerswithhigh-qualitypharmaceuticalservices.DeepenDTPprofessionalservicecapabilities.TheCompanyactivelycarriesoutcareprogramsfordiseasessuchasbreastcancer,skindiseases,leukemia,lungcancer,andhemophilia,strivingtomeetthemosturgentandprofessionalpharmaceuticalserviceneedsofpatientswithchronicandseverediseases.3.Improvemerchandisemanagement (1)TorchProjectinnovatesthecommercialprocurementsystem,improvingprofitabilityTheCompanycontinuestodeepentheTorchProject,comprehensivelypromotingtheinnovationofthecommercialprocurementsystemandkeybusinessprocesses.InQ12025,thegrossprofitmarginreached34.22%,withtheofflinesalesgrossprofitmarginofstoresincreasingby0.70percentagepointsyear-on-year.thecategorystructurelayout.Second,full-linkmanagementofnewproducts-establishathrough-mechanismfornewproductsfrommarketinsighttoterminalsales,quicklyrespondingtochangesinconsumptiontrends.Third,build an operational grading system - systematically plan product operation strategies through linkage of marketing,inventory,andprocurement.Fourth,strengthenpricecontrol-establishapricemonitoringsystemfortheentireproductlifecycletopreventmarketpricechaosandensuresalesprofit.Fifth,buildsystemcapabilities- continuouslyupgradethecommercialprocurementmanagementsystem,improvedatagovernance,andprovideprecisedatasupportforoperationaldecisions. (2)Merchandisedigitalizationandverticalmanagement,enhancingefficiencyContinuouslypromotethedigitalizationprocessofmerchandisemanagementandtheverticalmanagementmodel.Implementdifferentiatedcategoryoperations,leveragingdigitaltoolstoreduceinventoryturnoverdays. Attheendofthereportingperiod,theCompanyoperatedapproximately25,100SKUs(StockKeepingUnits).InQ12025,theCompany'sinventoryturnoverdayswere92days,adecreaseof13daysyear-on-year.Deepentheintegrationofprocurementchannelstoincreasetheproportionofcentralizedprocurement.Buildamutuallybeneficialsupplychainecosystembystreamliningprocurementanddistributionlinks,implementingmulti-dimensionalmarketanalysis,andsharingqualityresourceswithbrandowners.InQ12025,thesalesproportionofcentralizedprocurementwas75.3%,anincreaseofabout5.8percentagepointsyear-on-year.Continuouslyinnovateprivatelabelbrands,enhancingproductexperienceandcost-effectivenessbasedonconsumerneeds.InMarch2025,theCompany'sprivatelabel"vitasticRedNoseTissues"wonaninternationalauthoritativeaward-the2025MuseDesignAwardsGoldAward.Duringthereportingperiod,thesalesofprivatelabelbrandsinself-operatedstoresexceededRMB900million,accountingforabout23.3%ofsales,anincreaseof2.5percentagepointscomparedtothesameperiodlastyear. 4.Providewarmservice (1)Altruismculturepromotiondeeplyrooted,boostingmorale Continuouslyimplementthealtruismculturetoboostemployeemoraleandstoreservice.First,continuethe"AltruisticMindset"projectfrom2024,focusingon"7AltruisticDeeds"topromotetheconstructionofaltruismculture.Second,added"3Morale-BoostingDeeds"toencourageallemployeestoforgeaheadbravely,startanew,andfighttotheend.Third,jointlyformthe"2025AltruismMoraleBoosting"project,focusingonbenefitingfront-line employees andstorecustomers, boostingthemoraleofallemployees,promotingtheCompany'saltruismculture,andcomprehensivelyenhancingoverallmorale. (2)Chronicdiseasemanagementservicecaresforcustomers,enhancingstickinessFurtherenhancethedepthandwarmthofchronicdiseaseservices.First,customer-centric,relyondigitalintelligencetechnologytoformaclosedloopoffull-cyclehealthmanagementcoveringdiseaseprevention,monitoringintervention,andhealthguidanceSecond,systematicfilecreationmechanismsandregularhealthtrackingeffectivelyenhanceuserdependency.Third,enhancetheprofessionalservicecapabilitiesandhumanistic careleveloffront-lineemployeesthroughintelligentauxiliarysystemsandstandardizedserviceprocesses.AsoftheendofQ12025,theCompany'schronicdiseasemanagementservicehasaccumulatedfilesfor19.35million+people,served109million+self-tests,conducted32.46million+follow-upvisits(successfulcontactbasis),andheld35,000+onlineandofflinecustomerhealtheducationsessions.(3)Closed-loopmanagementsystemformemberoperations,refinedserviceRelyingonbigdatatechnologyandstorescenarioadvantages,theCompany'smemberoperationshaveestablishedacompleteclosed-loopmanagementsystem,andthecapabilityforrefinedmemberservicescontinuestoimprove.First,identifymemberneedsandprovideprecisefull-life-cyclehealthservices.Second,optimizememberexperienceandenhanceloyaltythroughbenefits,points,andpaidmemberships.Third,reviewmembermarketingstrategies,continuouslyincreasingtheproportionofmembersalesandconsumptionfrequency.Attheendofthereportingperiod,thetotalnumberofcompanymembers(includingfranchise)reachedmillionnewregisteredmemberswereaddedduringthereportingperiod,andmembersalesaccountedfor73%.5.Continueexploringinnovation (1)Deepintegrationofdigitalintelligencesystem,empoweringbusinessContinuouslypromotetheconstructionofthedigitalintelligencesystem,enhancingoperationalefficiencyandachievingcostoptimizationthroughtechnologicalinnovationanddeepbusinessintegration.InQ12025,thefollowing five measures were implemented: First, increase exploration in digital intelligence, expanding intelligentapplicationscenarios.Second,refinethecommercialprocurementsystemtosupportefficientandrefineddecision-making.Third,upgradenewretailbusinessstrategiesandexpandpilotscope.Fourth,closelyalignwithcorebusinessdemands,strengthendatagovernanceandlabelconstruction.Fifth,supportthefranchisebusiness,reducingtheout-of-stockrateforallfranchiseproductsby0.4percentagepoints.(2)Newretailendbolsteredbybigdata,maintainingaleadingpositionTheCompanyenrichesitsnewretailbusinessproductlines,enhancesintelligenceandbigdataapplications,andquicklyrespondstoconsumerneeds.Duringthereportingperiod,thetotalonlinechannelsales(includingfranchise)wereapproximatelyRMB750million,ayear-on-yearincreaseof34%.Asoftheendofthereportingperiod,theCompanyhad12,474storesofferingO2Odeliveryservicesand66524-hourstores.Inthepublicdomain,first,closelycollaboratewiththecommercialprocurementteamtorespondtouserneeds.Second,focusonbeingtheonlinecategoryleader,improvingproductsatisfactionandreducingproductout-of-stockrates.Third,simultaneouslydevelopmultiplechannels,multiplescenarios,andmultiplebusinessformatswithawiderangeofproducts.InQ12025,theCompany'sO2OandB2Csalesrankedfourthandthirdinthemarket,respectively. Intheprivatedomain,first,underoperationalstrategiesliketheNewYearGoodsperiodandstayingopenduringSpringFestival,privatedomainsalesincreasedby58.5%year-on-year.Second,horizontallyexpandtheprivatedomainproductassortment,withnewproductsalesaccountingforover18%.Third,implementmulti-codeintegration,loweringtheuseroperationthreshold,resultingina70%year-on-yearincreaseinMiniProgramMallDAU(DailyActiveUsers),peakingatover200,000. (3)Diversifiedeffortsinnon-pharmaceuticals,exploringincrementalgrowthIn Q1 2025, the Company continued to explore pharmacy diversification. First, continuing previousexplorations,successfullycreatedprototypesfor3diversifiedstores,withtheproportionofnon-pharmaceutical sales in these prototype stores increasing by 2.8 percentage points. Second, transferred several successful segmentedscenariobrandstotheGroup,totaling48SKUsingleproducts,distributedto5,800stores.(II)ExplanationofOperatingData 1.Mainbusinesssituationbyindustry
instoresincreasedby0.70percentagepointsyear-on-year. 2.Mainbusinesssituationbyproduct
ShandongProvince; NorthwestChinaregionincludes:ShaanxiProvince,GansuProvince,NingxiaHuiAutonomousRegion,GuizhouProvince. 4.Marketlayout 5,408franchisestores.Theoveralldistributionofdirectly-operatedstoresduringthereportingperiodisasfollows: Unit:Store
werenotincludedinthedirectly-operatedstorecaliber.TheactualrestoredefficiencyisRMB228/m,aYoYincreaseof1.3%.Theefficiencyofsmallandmedium-sizedestablishedstoresdecreasedbyRMB2persquaremetercomparedtothesameperiodlastyear,mainlyduetomarketenvironment,medicalinsurancepolicyimpacts,etc. (3)Thesituationofdirectly-operatedstoresobtainingmedicalinsurancequalificationsisasfollows:Duringthereportingperiod,9,158oftheCompany'sdirectly-operatedstoresobtainedvarious"designatedretailpharmacyformedicalinsurance"qualifications,withmedicalinsurancestoresaccountingfor93.03%.
Duringthereportingperiod,theCompanyanditssubsidiarieswereinvolvedin1acquisitionproject,withanacquisitionamountofRMB385million.Detailsareasfollows: 1.InJanuary2025,theCompanysignedanEquityTransferAgreementwiththeshareholdersofHunanLBXHuairenPharmacyChainCo.,Ltd.toacquirea20%stakeinHunanLBXHuairenPharmacyChainCo.,Ltd.forIV. QuarterlyFinancialStatements (I) Typeofauditopinion □Applicable√NotApplicable (II) FinancialStatements ConsolidatedBalanceSheet March31,2025 Preparedby:LBXPharmacyChainJointStockCompany Unit:YuanCurrency:RMBAuditType:Unaudited
 |